124 related articles for article (PubMed ID: 35426853)
1. Prognostic Potential of Postoperative 18F-Fluorocholine PET/CT in Patients With High-Grade Glioma. Clinical Validation of FuMeGA Postoperative PET Criteria.
García Vicente AM; Pena Pardo FJ; Amo-Salas M; Villena Martín M; López Menéndez C; Soriano Castrejón ÁM; Pérez-Beteta J
Clin Nucl Med; 2022 Jun; 47(6):480-487. PubMed ID: 35426853
[TBL] [Abstract][Full Text] [Related]
2. Early Recurrence Detection of Glioma Using 18 F-Fluorocholine PET/CT : GliReDe Pilot Study.
García Vicente AM; Amo-Salas M; Sandoval Valencia H; Lozano Setien E; Soriano Castrejón ÁM
Clin Nucl Med; 2022 Oct; 47(10):856-862. PubMed ID: 35835092
[TBL] [Abstract][Full Text] [Related]
3. FuMeGA Criteria for Visual Assessment of Postoperative 18F-Fluorocholine PET in Patients With Glioma.
García Vicente AM; Pena Pardo FJ; Lozano Setien E; Sandoval Valencia H; Villena Martín M
Clin Nucl Med; 2020 Jun; 45(6):448-450. PubMed ID: 32349093
[TBL] [Abstract][Full Text] [Related]
4. A Head-to-Head Comparison of
Garcia Vicente AM; Pérez-Beteta J; Amo-Salas M; Bosque JJ; Noriega-Álvarez E; Soriano Castrejon ÁM; Pérez-García VM
J Clin Med; 2022 Oct; 11(20):. PubMed ID: 36294385
[TBL] [Abstract][Full Text] [Related]
5. 18F-Fluorocholine PET/CT in the Prediction of Molecular Subtypes and Prognosis for Gliomas.
García Vicente AM; Pérez-Beteta J; Amo-Salas M; Pena Pardo FJ; Villena Martín M; Sandoval Valencia H; Mollejo Villanueva M; Barbella R; Klein Zampaña CJ; Borrás Moreno JM; Soriano Castrejón ÁM; Pérez-García VM
Clin Nucl Med; 2019 Oct; 44(10):e548-e558. PubMed ID: 31306196
[TBL] [Abstract][Full Text] [Related]
6. Metabolic imaging in recurrent gliomas: comparative performance of 18F-FDOPA, 18F-fluorocholine and 18F-FDG PET/CT.
Sharma A; Garg A; Singh M; Sharma MC; Gupta S; Kunhiparambath H; Tripathi M; Kale SS; Bal C
Nucl Med Commun; 2024 Feb; 45(2):139-147. PubMed ID: 38095139
[TBL] [Abstract][Full Text] [Related]
7. Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
Mulé S; Chalaye J; Legou F; Tenenhaus A; Calderaro J; Galletto Pregliasco A; Laurent A; Kharrat R; Amaddeo G; Regnault H; Tacher V; Kobeiter H; Itti E; Luciani A
Eur Radiol; 2020 Oct; 30(10):5348-5357. PubMed ID: 32405753
[TBL] [Abstract][Full Text] [Related]
8. Fluorocholine PET/CT predicts skeletal progression, skeletal event and cancer specific survival in patients with biochemical relapse for prostate cancer.
Zattoni F; Agostini E; Cattaneo F; Maruzzo M; Basso U; Zattoni F; Evangelista L
Clin Imaging; 2017; 43():110-116. PubMed ID: 28278446
[TBL] [Abstract][Full Text] [Related]
9. 18F-Fluorocholine PET/CT, Brain MRI, and 5-Aminolevulinic Acid for the Assessment of Tumor Resection in High-Grade Glioma.
García Vicente AM; Jiménez Aragón F; Villena Martín M; Jiménez Londoño GA; Borrás Moreno JM
Clin Nucl Med; 2017 Jun; 42(6):e300-e303. PubMed ID: 28319501
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and therapeutic impact of PET/CT with 18F-DCFPyL versus 18F-Fluorocholine in initial staging of intermediate-/high-risk prostate cancer: a pilot study.
Lucas Lucas C; García Zoghby L; Amo-Salas M; Soriano Castrejón ÁM; García Vicente AM
Ann Nucl Med; 2023 Oct; 37(10):551-560. PubMed ID: 37532975
[TBL] [Abstract][Full Text] [Related]
11. Comparison Between 18F-Dopa and 18F-Fet PET/CT in Patients with Suspicious Recurrent High Grade Glioma: A Literature Review and Our Experience.
Evangelista L; Cuppari L; Bellu L; Bertin D; Caccese M; Reccia P; Zagonel V; Lombardi G
Curr Radiopharm; 2019; 12(3):220-228. PubMed ID: 30644351
[TBL] [Abstract][Full Text] [Related]
12. Ischemic Complications After High-Grade Glioma Resection Could Interfere With Residual Tumor Detection With 18F-Fluorocholine PET/CT.
García Vicente AM; Rodriguez Muñoz MJ; Pena Pardo FJ; Martinez Madrigal MM; Soriano Castrejón A
Clin Nucl Med; 2019 Feb; 44(2):e76-e84. PubMed ID: 30516681
[TBL] [Abstract][Full Text] [Related]
13. Prospective study on diagnostic and prognostic significance of postoperative FDG PET/CT in recurrent colorectal carcinoma patients: comparison with MRI and tumor markers.
Odalovic S; Stojiljkovic M; Sobic-Saranovic D; Pandurevic S; Brajkovic L; Milosevic I; Grozdic-Milojevic I; Artiko V
Neoplasma; 2017; 64(6):954-961. PubMed ID: 28895416
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma.
Chalaye J; Costentin CE; Luciani A; Amaddeo G; Ganne-Carrié N; Baranes L; Allaire M; Calderaro J; Azoulay D; Nahon P; Seror O; Mallat A; Soussan M; Duvoux C; Itti E; Nault JC
J Hepatol; 2018 Aug; 69(2):336-344. PubMed ID: 29518452
[TBL] [Abstract][Full Text] [Related]
15.
Beheshti M; Hehenwarter L; Paymani Z; Rendl G; Imamovic L; Rettenbacher R; Tsybrovskyy O; Langsteger W; Pirich C
Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1762-1771. PubMed ID: 29516131
[TBL] [Abstract][Full Text] [Related]
16. Prediction of PSA Progression in Castration-Resistant Prostate Cancer Based on Treatment-Associated Change in Tumor Burden Quantified by 18F-Fluorocholine PET/CT.
Lee J; Sato MM; Coel MN; Lee KH; Kwee SA
J Nucl Med; 2016 Jul; 57(7):1058-64. PubMed ID: 26912444
[TBL] [Abstract][Full Text] [Related]
17. The usefulness of 18F-fluorocholine PET/CT in the detection of recurrence of central nervous system primary neoplasms.
Montes A; Fernández A; Camacho V; de Quintana C; Gallego O; Craven-Bartle J; López D; Molet J; Gómez-Ansón B; Carrió I
Rev Esp Med Nucl Imagen Mol; 2017; 36(4):227-232. PubMed ID: 28219644
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of tumor recurrences after radical prostatectomy using 18F-Choline PET/CT and 3T multiparametric MRI without endorectal coil: a single center experience.
Couñago F; Recio M; Maldonado A; Del Cerro E; Díaz-Gavela AA; Thuissard IJ; Sanz-Rosa D; Marcos FJ; Olaciregui K; Mateo M; Cerezo L
Cancer Imaging; 2016 Dec; 16(1):42. PubMed ID: 27927229
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of imaging techniques for detecting of local recurrence after prostate brachytherapy.
Karahissarlian V; Sargos P; Blais E; Cazeau AL; Fontes F; Petitpierre F; Rigou G; De Vaugelade C; Mariey A; Hindié E; Thomas L
Cancer Radiother; 2020 Jul; 24(4):323-331. PubMed ID: 32532578
[TBL] [Abstract][Full Text] [Related]
20. Identification of Occult Adenomas in Primary Hyperparathyroidism With 18F-fluorocholine PET/CT.
Ballester Vázquez E; Pérez García JI; López Mora DA; Galán Martínez C; Pareja Nieto E; Clos Enrríquez M; González López JA; Moral Duarte A
Cir Esp (Engl Ed); 2020; 98(7):395-402. PubMed ID: 32115188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
